Terminated PHASE2 INTERVENTIONAL 4-arm NCT00471237

A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

Study CR9108963: A 12-month, Randomized, Double-blind, Parallel-group, Placebo and Active-controlled Dose-range Finding Study of the Efficacy and Safety of SB-751689 in Post-menopausal Women With Osteoporosis

Sponsor: GlaxoSmithKline

Conditions Osteoporosis

Interventions Alendronate Ronacaleret Teriparatide

Updated 9 times since 2017 Last updated: Oct 9, 2017 Started: May 14, 2007 Primary completion: Dec 26, 2008 Completion: Dec 26, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Terminated for futility by sponsor after a pre-planned interim review of data

Other terminated trials from GlaxoSmithKline

See all terminations from GlaxoSmithKline

This PHASE2 trial investigates Osteoporosis and is currently terminated or withdrawn. GlaxoSmithKline leads this study, which shows 9 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE2
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE2

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Oct 2017 — Jun 2018 [monthly]

Terminated PHASE2
Feb 2017 — Oct 2017 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Ballerup Municipality, Denmark , Barcelona, Spain , Bergen, Norway , Berlin, Germany , Bethesda, United States , Buenos Aires, Argentina , Ciudad Autónoma de Buenos Aires, Argentina , Cleveland, United States , Decatur, United States and 30 more locations